Global Patient Derived Xenograft (PDX) Models Market Report 2024: Size, Drivers, And Top Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
How is the Patient Derived Xenograft (PDX) ModelsMarket Expected to Expand from 2024 to 2033?
The patient-derived xenograft (PDX) models market size has seen rapid growth in recent years. It is expected to grow from $0.35 billion in 2023 to $0.4 billion in 2024, reflecting a compound annual growth rate (CAGR) of 16%. The historical growth can be attributed to investments in research and development, regulatory support, partnerships and collaborations, a rising number of contract research organizations (CROs), and the increasing prevalence of cancer cases.
The patient-derived xenograft (PDX) models market is anticipated to grow rapidly, projected to reach $0.74 billion by 2028, with a CAGR of 16.1%. This growth is driven by the demand for personalized medicine, the rising need for humanized PDX models, an increase in cancer cases, a focus on precision oncology, and greater investments in cancer research. Key trends during this period include technological advancements, a rising demand for humanized PDX models, collaborative research efforts, increased funding for cancer studies, and a heightened emphasis on immuno-oncology.
What Influences Are Propelling the Patient Derived Xenograft (PDX) Models Market Forward?
The demand for personalized medicine is projected to fuel the growth of the patient-derived xenograft (PDX) models market in the coming years. Personalized medicine involves customizing medical treatments to each patient’s unique characteristics, factoring in elements such as genetics, environment, and lifestyle. This growing demand is driven by advancements in genomic research, allowing for treatments tailored to individual genetic profiles, ultimately leading to more effective healthcare outcomes. Patient-derived xenograft (PDX) models contribute to personalized medicine by facilitating the testing of individual patient tumors, which helps predict treatment responses and tailor therapies. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a substantial increase from six approvals in 2022. Thus, the rising demand for personalized medicine is propelling growth in the patient-derived xenograft (PDX) models market.
Claim Your Free Sample of the Global Patient Derived Xenograft (PDX) Models Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=17226&type=smp
What Key Segments Exist Within the Patient Derived Xenograft (PDX) Models Market?
The patient derived xenograft (PDX) models market covered in this report is segmented –
1) By Type: Mice Models, Rat Models
2) By Technique: Heterotopic Implantation, Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models
4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research
5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users
What Trends Are Coming to the Forefront in the Patient Derived Xenograft (PDX) Models Market?
Companies in the patient-derived xenograft (PDX) models market are creating innovative models equipped with in vivo bioluminescence imaging for real-time tumor growth monitoring. This imaging technique allows non-invasive tracking of tumor progression and treatment responses. For example, in March 2024, InVitro Research Solutions Private Limited, an India-based CRO, launched an orthotopic model of human glioblastoma in NSG-SGM3 mice using PDX and bioluminescence imaging to enable personalized glioblastoma treatment.
Order Now for Fast Delivery of Your Patient Derived Xenograft (PDX) Models Market Report!
What Regions Are Leading the Charge in the Patient Derived Xenograft (PDX) Models Market?
North America was the largest region in the patient derived xenograft (PDX) models market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient derived xenograft (PDX) models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Patient Derived Xenograft (PDX) Models Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the patient derived xenograft (pdx) models market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Patient Derived Xenograft (PDX) Models Market Include
1. Patient Derived Xenograft (PDX) Models Market Executive Summary
2. Patient Derived Xenograft (PDX) Models Market Segments
3. Patient Derived Xenograft (PDX) Models Market Size And Template Market Growth Rate
4. Key Patient Derived Xenograft (PDX) Models Market Trends
5. Major Patient Derived Xenograft (PDX) Models Market Drivers
……
25. Key Mergers And Acquisitions In The Patient Derived Xenograft (PDX) Models Market
26. Top Patient Derived Xenograft (PDX) Models Companies
27. Patient Derived Xenograft (PDX) Models Market Opportunities And Strategies
28. Patient Derived Xenograft (PDX) Models Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Patient Simulators Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-simulators-global-market-report
Patient Portal Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-portal-global-market-report
Patient Safety And Risk Management Software Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
